Company intelligence
ConcertAI
Biotechnology Research
Cambridge, US
855 employees
4 public signals
About ConcertAI
ConcertAI orchestrates clinical expertise, real-world data and applied AI to deliver practical intelligence for the demands of treating oncology and other complex diseases.
Verified activity
Signals from ConcertAI
4 published signals
Products & Services
ConcertAI's CancerLinQ network helps oncology teams shift from retrospective reporting to real-time insight to catch care gaps and reduce manual abstraction time.
Reported by ConcertAI
Research & Knowledge
ConcertAI CEO Eron Kelly published a new article for MedCity News outlining how agentic AI is helping move complex work from reactive management to continuous orchestration.
Reported by ConcertAI
Presence & Recognition
ConcertAI announced the Drive Fall 2026 program companies were exceptional this year.
Reported by Jeff Elton
Research & Knowledge
ConcertAI CEO Eron Kelly and Chief Medical Officer, Oncology Shaalan Beg MD MBA FASCO discuss how AI reasoning models turn weeks-long trial design into minutes while identifying trial sites based on historical patient populations to speed enrollment.
Reported by ConcertAI